Biofrontera Inc. Reports Q2 2026 Financial Results

What Happened

• On August 13, 2026, Biofrontera Inc. announced its financial and operational results for the three and six months ended June 30, 2026 and furnished the related press release as Exhibit 99.1 to a Form 8-K. The press release contains non-GAAP financial measures and, in compliance with Regulation G, includes quantitative reconciliations to the most directly comparable GAAP measures.

Key Details

• Filing date: August 13, 2026 (Form 8-K, Item 2.02).
• Period covered: three and six months ended June 30, 2026 (quarter and year-to-date results).
• Press release furnished as Exhibit 99.1; cover page XBRL tags embedded in the inline XBRL document (Exhibit 104).
• Press release discloses non-GAAP measures and provides reconciliations to GAAP figures per Regulation G.

Why It Matters

• The 8-K provides the company’s latest quarterly and first-half 2026 financial and operational information investors use to assess performance.
• Inclusion of non-GAAP measures with reconciliations lets investors compare management’s adjusted metrics to GAAP results; review the furnished press release for the full figures and reconciliations before making investment decisions.